Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Bogner

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
HIV Medicine|August 19, 2011
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*A Cozzi-Lepri, Paredes, A N Phillips, et al.
The Journal of Infection|September 30, 2010
Influence of antiretroviral therapy on immunogenicity of simultaneous vaccinations against influenza, pneumococcal disease and hepatitis A and B in human immunodeficiency virus positive individualsS Horster, R P Laubender, L Lehmeyer, et al.
Journal of Neurology|July 1, 1989
Myelin basic protein in the cerebrospinal fluid of patients infected with HIVH W Pfister, K M Einhäupl, M Wick, et al.
AIDS (London, England)|February 24, 2001
Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapyF D Goebel, R Hemmer, J C Schmit, et al.
HIV Medicine|February 26, 2015
Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialA J Rodger, F C Lampe, A E Grulich, et al.
European Journal of Medical Research|February 18, 2010
HIV-induced immune activation: pathogenesis and clinical relevance - summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008Hans-Jürgen Stellbrink, S Baldus, G Behrens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2006
Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter studyM Hentrich, L Maretta, K U Chow, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1997
Patterns of mycobacterium avium culture and PCR positivity in immunodeficient HIV-infected patients: progression from localized to systematic disease, German Aids Study Group (GASG/IDKF)J R Bogner, S Rüsch-Gerdes, T Mertenskötter, et al.
Epidemiology and Infection|October 27, 2016
Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in GermanyC Schwarze-Zander, R Draenert, C Lehmann, et al.
Journal of Medical Virology|August 16, 2001
Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assaysO Schatz, P Monini, R Bugarini, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
HIV Medicine|August 19, 2011
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*A Cozzi-Lepri, Paredes, A N Phillips, et al.
The Journal of Infection|September 30, 2010
Influence of antiretroviral therapy on immunogenicity of simultaneous vaccinations against influenza, pneumococcal disease and hepatitis A and B in human immunodeficiency virus positive individualsS Horster, R P Laubender, L Lehmeyer, et al.
Journal of Neurology|July 1, 1989
Myelin basic protein in the cerebrospinal fluid of patients infected with HIVH W Pfister, K M Einhäupl, M Wick, et al.
AIDS (London, England)|February 24, 2001
Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapyF D Goebel, R Hemmer, J C Schmit, et al.
HIV Medicine|February 26, 2015
Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialA J Rodger, F C Lampe, A E Grulich, et al.
European Journal of Medical Research|February 18, 2010
HIV-induced immune activation: pathogenesis and clinical relevance - summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008Hans-Jürgen Stellbrink, S Baldus, G Behrens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2006
Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter studyM Hentrich, L Maretta, K U Chow, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1997
Patterns of mycobacterium avium culture and PCR positivity in immunodeficient HIV-infected patients: progression from localized to systematic disease, German Aids Study Group (GASG/IDKF)J R Bogner, S Rüsch-Gerdes, T Mertenskötter, et al.
Epidemiology and Infection|October 27, 2016
Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in GermanyC Schwarze-Zander, R Draenert, C Lehmann, et al.
Journal of Medical Virology|August 16, 2001
Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assaysO Schatz, P Monini, R Bugarini, et al.
Pageof 14